NSN 6505-01-340-4829 of Clonazepam Tablets Usp - Parts Details
| Alternative NSN: 6505013404829 |
| Item Name: Clonazepam Tablets Usp |
| FSG: 65 Medical Dental and Veterinary Equipment and Supplies |
| Federal Supply Class (FSC): 6505 Drugs and Biologicals |
| NIIN: 013404829 |
| NCB Code: USA (01) |
| Manufacturers: Falcon Pharmaceuticals Ltd , Mylan Institutional Llc , Major Pharmaceuticals Llc , Danbury Pharmacal Inc , Mylan Pharmaceuticals Inc , Actavis Inc , Sandoz Inc , Eon Labs Llc , Goldline Laboratories Inc , Lemmon Co , Hoffmannla Roche Inc |
ASAP Aviation Procurement, owned and operated by ASAP Semiconductor, is the latest parts procurement platform for the aerospace and aviation industry. Check out high demanding part numbers NDC60505-0067-01, NDC51079-0882-21, NDC51079-0882-01, NDC00904-5343-60, NDC00591-0747-01 under NSN 6505-01-340-4829 of Clonazepam Tablets Usp manufactured by Falcon Pharmaceuticals Ltd, Mylan Institutional Llc, Major Pharmaceuticals Llc, Danbury Pharmacal Inc, Mylan Pharmaceuticals Inc.
Federal Supply Class of NSN 6505-01-340-4829 is FSC 6505 contains part details of Drugs and Biologicals. Quote for your desired part numbers.
Part Number's List for NSN 6505-01-340-4829, 6505013404829
-
Part No Manufacturer Item Name QTY RFQ NDC60505-0067-01 Falcon Pharmaceuticals Ltd clonazepam tablets usp Avl RFQ NDC51079-0882-21 Mylan Institutional Llc clonazepam tablets usp Avl RFQ NDC51079-0882-01 Mylan Institutional Llc clonazepam tablets usp Avl RFQ NDC00904-5343-60 Major Pharmaceuticals Llc clonazepam tablets usp Avl RFQ NDC00591-0747-01 Danbury Pharmacal Inc clonazepam tablets usp Avl RFQ NDC00378-1912-01 Mylan Pharmaceuticals Inc clonazepam tablets usp Avl RFQ NDC00228-3004-11 Actavis Inc clonazepam tablets usp Avl RFQ NDC00185-0064-01 Sandoz Inc clonazepam tablets usp Avl RFQ NDC00185-0064-01 Eon Labs Llc clonazepam tablets usp Avl RFQ NDC00182-8229-89 Goldline Laboratories Inc clonazepam tablets usp Avl RFQ NDC00093-0833-01 Lemmon Co clonazepam tablets usp Avl RFQ NDC00004-0058-01 Hoffmannla Roche Inc clonazepam tablets usp Avl RFQ
Characteristics Data of NSN 6505013404829MRC Criteria Characteristic AJCN PROTECTIVE STORAGE FEATURE SECURITY STORAGE AKJA ACTIVE MEDICAMENT MEDICINAL STRENGTH 1.000 MILLIGRAMS CLONAZEPAM ACTIVE INGREDIENT CBBL FEATURES PROVIDED INDIVIDUALLY SEALED CQCT PRIMARY CONTAINER TYPE STRIP, REVERSE NUMBERED CRLK PRIMARY CONTAINER CONTENT QUANTITY 25.000 TABLETS CSCW TOTAL PRIMARY CONTAINER QUANTITY 4 CXCY III PART NAME ASSIGNED BY CONTROLLING AGENCY CLONAZEPAM TABLETS USP 1MG I.S. 100S PG MDES MEDICAL DESIGNATION AND GRADE UNITED STATES PHARMACOPEIA FEAT SPECIAL FEATURES UNIT DOSE; REVERSE NUMBER PACK
| MRC | Criteria | Characteristic |
|---|---|---|
| AJCN | PROTECTIVE STORAGE FEATURE | SECURITY STORAGE |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 1.000 MILLIGRAMS CLONAZEPAM ACTIVE INGREDIENT |
| CBBL | FEATURES PROVIDED | INDIVIDUALLY SEALED |
| CQCT | PRIMARY CONTAINER TYPE | STRIP, REVERSE NUMBERED |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 25.000 TABLETS |
| CSCW | TOTAL PRIMARY CONTAINER QUANTITY | 4 |
| CXCY | III PART NAME ASSIGNED BY CONTROLLING AGENCY | CLONAZEPAM TABLETS USP 1MG I.S. 100S PG |
| MDES | MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| FEAT | SPECIAL FEATURES | UNIT DOSE; REVERSE NUMBER PACK |